Finivi Inc’s CVS Health CVS Stock Holding History

Finivi Inc’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-10,816	Closed	-$639K	–	89
2024 Q2	$639K	Buy	10,816 +659	+6%	+$41.2K	0.53%	48
2024 Q1	$810K	Buy	10,157 +100	+1%	+$7.64K	0.73%	37
2023 Q4	$794K	Buy	+10,057	New	+$716K	0.78%	38
2021 Q4	$1.07M	Buy	+10,361	New	+$957K	1.13%	34

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Finivi Inc's CVS Position: Q3 2024 in Review

Finivi Inc sold out of CVS Health (CVS) in Q3 2024, closing a stake of 10,816 shares — an estimated $639K sold.

Finivi Inc first reported a position in CVS in Q4 2021 and held it in 4 quarters. The position peaked at $1.07M in Q4 2021. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

Finivi Inc reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
Finivi Inc sold 10,816 CVS Health shares in Q3 2024, an estimated $639K.
Finivi Inc first reported a position in CVS Health in Q4 2021 and held it in 4 quarters.
Finivi Inc's CVS Health position peaked at $1.07M in Q4 2021.
1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Finivi Inc's 13F filing for Q3 2024, filed 19 Dec 2025.